MYLeukaemia

MYLeukaemia

UPTEC Asprela I

At MYLeukaemia, we believe that every blood cancer patient deserves a personalized treatment plan using the most advanced technology science has to offer. That’s why we are building something truly revolutionary: the MYLeukaemia Therapy Guidance Chipset – a cutting-edge Organ-on-Chip platform that personalizes cancer treatment like never before. Imagine recreating a patient’s bone marrow outside the body—a perfect human replica—to test therapies and predict responses before a single treatment is given. No guesswork. No unnecessary suffering. Just precision. That’s what we will deliver to more than 2 million people fighting blood cancer. Our i3S developed technology, recreates a patient’s bone marrow microenvironment at an unprecedent level, providing Haematologists, unprecedent access to innovative Organ-on-Chip technology in their everyday. In one simple test, you can uncover how your patient’s unique cancer cells respond to multiple available therapies, providing you the tools to make the right call to extent your patients live. For patients, this means better outcomes, more time, and fewer side effects. Our technology doesn’t just change how we treat patients—it redefines how we create treatments. By delivering precise, human-relevant data, MYLeukaemia fast-track drug development, eliminate pointless animal testing, and cut costs. It’s smarter, faster, and the future of precision medicine.

Email